MOON, Sung Hwan,LEE, Soo Jin,LEE, Sung Chan,BAE, Yun Soo
申请号：
EP18871904
公开号：
EP3573617A4
申请日:
2018.09.14
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Disclosed is a pharmaceutical composition for preventing or treating a fatty liver disease containing, as an active ingredient, a pyrazole-based compound or a pharmaceutically acceptable salt thereof. 3-phenyl-4-alkyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol or a pharmaceutically acceptable salt thereof is capable of effectively inhibiting fatty liver, hepatic inflammation and hepatic fibrosis, and is useful for preventing or treating NAFLD, in particular, NASH.
